Skip to main navigation Skip to search Skip to main content

A Randomized, Open-Label, Controlled, Multi-Center study to Compare the Efficacy and Safety of Intravitreal Ranibizumab with Laser Therapy in Patients with Retinopathy of Prematurity

Project: Research

Project Details

StatusFinished
Effective start/end date01/12/17 → 01/12/19

Funding

  • Novartis Pharmaceuticals Corporation: $13,500.00